“…39,41,42,53,54,[58][59][60][61][62][63][64]74,75) are comparable to ours (respectively 100% and 87.6%), as well as the recipient survival rates at 1 (89.7-100%, Ref. 38,39,41,42,44,52,[54][55][56]59,[61][62][63]75,77,78) and 3 years (80-97.5%, Ref. 39,41,42,54,[58][59][60][61][62][63]75), both at 97.4% in our series.…”